Trump's trade threats and tariffs target various countries and industries, sparking fears of a global trade war.
Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated dual PARP/Wnt pathway ...
Total Revenues of $491.7 Million, Marking Another Year of Record GrowthFull Year 2024 Total Revenues Grew 23.5% YoY, Driven by ...
A case study on how one of the leading pharma companies in the oncology space approached DelveInsight with a pressing need for conference coverage to monitor the activities and data readouts of ...
The global ankylosing spondylitis treatment market is experiencing steady growth, driven by advancements in therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results